|
|
|
|
Expert Todd Sprouse, Associate Director of Analytical Services, shares practical insights and case studies demonstrating how a tailored testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.
|
|
|
|
|
Testing for nitrosamines, potential carcinogens found in food, beverages, cosmetics, and pharmaceuticals, is essential in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and drug products to ensure safety and compliance.
|
|
|
|
|
|
|
With a Ph.D. in bioanalytical chemistry from the University of Alaska Fairbanks, Kirschner brings nearly 15 years of experience in pharmaceutical development across biotech and CDMO sectors.
|
|
|
|
|
|
Advanced Solutions For Impurity Detection
|
Pinpoint impurities and conduct confirmatory testing under cGMP with the help of an expert team utilizing cutting-edge mass spectrometry technology and tailored analytical methodologies to help boost your innovative drug product development.
|
|
• Request Information
|
|
|
|
|
|
|
|
